PHI1.F · Koninklijke Philips N.V

-

Please sign in to comment on PHI1.F

1 Comment

Admin

4 years, 11 months ago

Koninklijke Philips N.V is currently in a long term downtrend where the price is trading 13.2% below its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.

Koninklijke Philips N.V's total revenue rose by 0.7% to $6B since the same quarter in the previous year.

Its net income has increased by 8.6% to $603M since the same quarter in the previous year.

Finally, its free cash flow fell by 0.0% to $139M since the same quarter in the previous year.

Based on the above factors, Koninklijke Philips N.V gets an overall score of 3/5.

ISIN	NL0000009538
Exchange	F
CurrencyCode	EUR
Sector	Healthcare
Industry	Medical Devices

Target Price	None
Beta	0.94
Dividend Yield	3.3%
PE Ratio	26.55
Market Cap	23B

ABOUT

Koninklijke Philips N.V

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

PHI1.F · Koninklijke Philips N.V

-

Koninklijke Philips N.V

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Koninklijke Philips N.V using a moving average strategy